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Abstract 
Introduction: serious thrombembolic events occur in
otherwise healthy marathon athletes during competi-
tion. We tested the hypothesis that during heavy en-
durance sports coagulation and platelets are activated
depending  on  the  type  of  endurance  sport  with  re-
spect to its running fraction. 
Materials and Methods: 68 healthy athletes participat-
ing  in  marathon  (MaR,  running  42  km,  n  =  24),
triathlon (tRI, swimming 2.5 km + cycling 90 km +
running  21  km,  n  =  22),  and  long  distance  cycling
(CyC, 151 km, n = 22) were included in the study.
Blood samples were taken before and immediately af-
ter completion of competition to perform rotational
thrombelastometry.We assessed coagulation time (Ct),
maximum clot firmness (MCf) after intrinsically acti-
vation and fibrin polymerization (fIBtEM). further-
more, platelet aggregation was tested after activation
with adP and thrombin activating peptide 6 (tRaP)
by using multiple platelet function analyzer.
Results: Complete data sets were obtained in 58 ath-
letes (MaR: n = 20, tRI: n = 19, CyC: n = 19). Ct
significantly decreased in all groups (MaR -9.9%, tRI
-8.3%,  CyC  -7.4%)  without  differences  between
groups. In parallel, MCf (MaR +7.4%, tRI +6.1%,
CyC  +8.3%)  and  fibrin  polymerization  (MaR
+14.7%, tRI +6.1%, CyC +8.3%) were significantly
increased in all groups. However, platelets were only
activated  during  MaR  and  tRI  as  indicated  by  in-
creased auC during tRaP-activation (MaR +15.8%)
and  increased  auC  during  adP-activation  in  MaR
(+50.3%) and tRI (+57.5%). 
Discussion: While coagulation is activated during phys-
ical activity irrespective of type we observed signifi-
cant platelet activation only during marathon and to a
lesser extent during triathlon. We speculate that pro-
longed running may increase platelet activity, possibly,
due  to  mechanical  alteration.  thus,  particularly  pro-
longed running may increase the risk of thrombem-
bolic incidents in running athletes.
IntRoduCtIon
Popularity of marathon running has increased during
the last decade. today, out of 17 million non profes-
sional runners in germany, 100.000 runners partici-
pate in marathon competitions. thrombembolic events
have been reported in marathon athletes during com-
petition  accounting  for  considerable  morbidity  and
mortality  in  otherwise  healthy  subjects  even  in  the
most experienced runners [1-7]. In previous studies,
activation of coagulation and platelets were demon-
strated during marathon [8-23]. although during other
endurance sports heavy exercise is performed for sev-
eral  hours  severe  thrombembolic  events  occur  only
very rarely. accordingly, we tested the hypothesis that
coagulation  and  platelet  activation  are  influenced  by
the type of endurance sport with respect to different
running fractions.
MatERIal and MEtHods
the  study  protocol  was  approved  by  the  university
Hospital d￼sseldorf ethic committee and is consistent
with the Revised Helsinki declaration and European
unions Convention on Human Rights and Biomedi-
cine.  the  study  was  conducted  at  the  toyota  yvel
d￼sseldorf Marathon 2007 (42 km running), Cologne
Classic triathlon 2007 (2.5 km swimming, 90 km cy-
cling, 21 km running) and the Remscheid Round 2007
(151 km cycling). 
PaRtICIPants
68 male volunteers (marathon (MaR) n = 24; triathlon
(tRI) n = 22; cycling (CyC) n = 22) participated in
the study after oral and written information and writ-
ten consent. 
all volunteers were requested to complete a ques-
tionnaire providing information on medical and train-
ing  status.  athletes  with  manifestation  of  coagu-
lopathies,  previous  thromboembolic  incidents,  or
medication  altering  coagulation  or  platelet  function
were excluded from the study.
Blood saMPlEs
Blood samples were taken from a forearm vein using a
0.9 mm diameter needle and were collected in tubes
containing either citatrate or hirudin for anticoagula-
tion  (vacutainer,  Becton  dicinson,  Heidelberg,  ger-
many)  immediately  before  and  after  completion  of
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3. Hanke_Umbruchvorlage  12.02.10  11:10  Seite 59competition. Citrated tubes were assigned with rota-
tional thrombelastometry, hirudin tubes were assigned
with aggregometry.
Platelet  count,  hemoglobin  concentration,  hemat-
ocrit, and leukocyte count were measured by an auto-
mated  hematology  analyzer  (sysmex  mo.  KX-21n,
norderstedt, germany).
WHolE Blood CoagulatIon
Whole blood coagulation was assessed by rotational
thrombelastometry  (RotEM,  Pentapharm,  Munich,
germany) which is a modification of the thrombelas-
tograph system [24]. RotEM analyses correlate well
with  conventional  thrombelastography.  By  using  a
ball-bearing  stabilization  RotEM  is  less  sensitive
against mechanical stress and agitation than classical
thrombelastography.  accordingly,  RotEM  shows
good reproducibility and precision during bed site ap-
plication. analysis can be performed on four channels
at the same time testing different activators of coagu-
lation. Whole blood coagulation was determined after
intrinsically activation by calcium chloride, phospho-
lipids and ellagic acid (IntEM assay). fibrin polymer-
ization was assessed after activation by calcium chlo-
ride and tissue factor with addition of Cytochalasin d
to  disable  platelet  function  and  display  fibrin  poly-
merization  only  (fIBtEM  assay  –  both  assays 
Pentapharm, Munich, germany). We measured coagu-
lation time (Ct, times from beginning of the reaction
until  start  of  clot  formation  corresponding  to 
reaction  time  in  classical  thrombelastography)  and
maximum  clot  firmness  (MCf,  clot  stability  at  its
highest degree which is equivalent to maximum am-
plitude).
PlatElEt funCtIon
Platelet function was assessed using a multiple platelet
function analyzer (Multiplate, dynabyte, Munich, ger-
many).  While  platelets  are  non-thrombogenic  in  the
resting state, they expose receptors when activated by
specific  agents.  Multiplate  test  cells  are  constructed
with two pairs of sensor wires serving as internal con-
trol.  after  platelet  activation  ex  vivo  platelets  coat
these sensor wires of the analyser. the extent of coat-
ing is determined by increased electrical resistance be-
tween these wires. alterations in resistance are record-
ed  continuously  as  a  measure  of  platelet  activation.
accordingly,  the  degree  of  platelet  aggregation  is
quantified by planimetry of the area under this curve
(auC) indicating overall platelet activity. for assess-
ment of platelet function platelets were activated by
thrombin activating peptide (tRaP-6, tRaPtest) and
by adenosine-di-phosphate (adP, adPtest, both as-
says dynabyte, Munich, germany). 
statIstICal analysIs
data  are  expressed  as  means  (ﾱ  standard  deviation,
sd). the statistical Package for social sciences (sPss
for Windows, 13.0, sPss Inc., Chicago, Il., usa) and
graphPad  Prism  (version  4.02,  graphPad  software
Inc., san diego, Ca., usa) were used. data were posi-
tively tested for normal distribution and were then an-
alyzed  using  paired  student’s  t-tests  for  comparison
before and after competition and analysis of variance
with Bonferroni correction for comparing the impact
of the type of sport. a p-value below 0.05 was consid-
ered to be significant.
REsults
Complete  data  sets  were  obtained  in  58  athletes
(MaR: n = 21, tRI: n = 19, CyC: n = 19). Exclusion
from  the  study  was  caused  by  early  termination  of
competition or a time delay with excessive fluid resus-
citation  before  blood  sampling  after  completion  of
competition. 
demographic data including age and weekly hours
of physical activity as well as hemogram results are
displayed in table 1. significant differences between
groups were found for age, but not for weekly training
hours. no significant differences were found between
haemoglobin levels pre und and post competition in
all groups. Platelet concentrations were significantly al-
tered during MaR and tRI without reaching statistical
significance between groups. a significant increase of
leukocyte levels was found in all groups with a signifi-
cant higher increase in MaR and tRI.  
EuRoPEan JouRnal of MEdICal REsEaRCH 60 february 26, 2010
Table 1. demographic data of study participants.
Marathon Triathlon Cycling p (ANOVA)
age (years) 43 ﾱ 8.4 36.5 ﾱ 6.3 41.7 ﾱ 12.2 0.0429*
Physical activity (hours/week)  7.9 ﾱ 9.3 11.1 ﾱ 5.0 12.2 ﾱ 9.8 0.2081
Hemoglobin before (g/l) 15.0 ﾱ 0.8 15.7 ﾱ 0.9 15.1 ﾱ 1.2 0.1281
Hemoglobin after (g/l) 15.2 ﾱ 0.7 15.5 ﾱ 0.9 15.5 ﾱ 1.6 0.9234
Platelets before (ﾵl-1) 239.3 ﾱ 36.5 224.5 ﾱ 43.2 250.1 ﾱ 62.4 0.6103
Platelets after (ﾵl-1l) 286.0 ﾱ 42.5 # 261.3 ﾱ 51.6 # 247.9 ﾱ 62.4 0.0650
leucocytes before competition (ﾵl-1) 5.3 ﾱ 1.0 5.9 ﾱ 1.1 5.5 ﾱ 1.2 0.2331
leucocytes after competition (ﾵl-1l) 16.8 ﾱ 3.2 # 16.6 ﾱ 3.8 # 11.4 ﾱ 3.2# <0.0001*
data are displayed as mean ﾱ standard deviation. p<0.05. 
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nificantly  decreased  in  whole  blood  coagulation  in
MaR (-9.9%), tRI (-8.3%), and CyC (-7.4%) during
competition. In parallel, MCf after intrinsically activa-
tion increased in all groups (fig. 1) with a greater in-
crease  in  MaR  (+7.4%)  and  CyC  (+8.3%)  than  in
tRI (+6.1%) (table 2). fibrin polymerization signifi-
cantly increased in all groups (fig. 2) with a significant
larger increase in MaR (+14.7%) and CyC (+17.7%)
than in tRI (+11.2%). 
Platelets  aggregation  ex  vivo  was  enhanced  de-
pending on the duration of running. after  comple-
tion of competition platelet aggregation was signifi-
cantly increased in MaR after both tRaP (+15.8%)
and adP (+50.3%) activation. In tRI aggreagation
increased  after  adP  activation  only  (+57.5%).  In
CyC  no  activity  dependent  differences  in  platelet 
aggregation  were  recognized  (tRaP  -6.6%,  adP
+6.5%) (table 2/fig. 3). 
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Table 2. Results of thrombelastometry (RotEMﾮ) and impedance aggregometry (Multiplateﾮ) before and after competition.
Marathon Triathlon Cycling p (ANOVA)
ROTEMﾮ Whole blood coagulation results
Ct IntEM before (s) 172 ﾱ 15.3 168.1 ﾱ 12.9 164.7ﾱ17.7 0.3956
Ct IntEM after (s) 155 ﾱ 18.3 # 154.2 ﾱ 11.3 # 152.5 ﾱ 13.0 # 0.9255
MCf IntEM before (mm) 58.1 ﾱ 3.9 56.1 ﾱ 3.2 59.3 ﾱ 5.0 0.0823
MCf IntEM after (mm) 62.4 ﾱ 3.8 # 59.5 ﾱ 3.1 # 64.2 ﾱ 4.2 # 0.0013 *
MCf fIBtEM before (mm) 10.9 ﾱ 2.7 8.9 ﾱ 2.8 9.6 ﾱ 3 0.0928
MCf fIBtEM after (mm) 12.5 ﾱ 3 # 9.9 ﾱ 2.4 # 11.3 ﾱ 2.4 # 0.0136 *
Multiplateﾮ impedance aggregometry results
auC tRaP activation before (g/l) 899 ﾱ 149 911 ﾱ 233 970 ﾱ 186   0.4672
auC tRaP activation after (g/l) 1041 ﾱ 209 # 1009 ﾱ 315 906 ﾱ 288 0.3492
auC adP activation before (g/l) 529 ﾱ 174 508 ﾱ 178 589 ﾱ 160   0.1281
auC adP activation after (g/l) 795 ﾱ 258 # 800 ﾱ 320 # 627 ﾱ 219 0.0865
data are displayed as mean ﾱ standard deviation. (p<0.05)  note, that results, obtained by thrombelastometry, show a signifi-
cant increase of clot stability and shortening of coagulation times, while platelet aggregation is increased only in MaR and tRI
after adP activation, respectively in MaR after tRaP activation, but not in CyC. (* mark significant differences between
groups, # mark significant differences as compared to baseline values)
Fig. 1. Results of rotational thrombelastometry after intrinsically activation before and after competition. Maximum clot firm-
ness (MCf) significantly increased in all groups (left panel). Clotting times (Ct) significantly decreased in all groups (right pan-
el). * p<0.05.
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after completing the first “marathon-run” ever from
Marathon to athens 2500 years ago, Pheidippides died
[25, 26]. today morbidity and mortality during mara  -
thon running are still considerably. Mortality varies with
age  from  0.3/100.000  in  young  athletes  [27,  28]  to
7/100.000 in elderly runners [29]. an analysis of the
london marathon (650.000 completed runs) indicated
an average cardiac death rate of 1.25/100.000 [30]. al-
though  the  most  frequent  disease  associated  with
deaths  during  marathon  is  previously  unrecognized
coronary artery disease [30, 31] other thrombembolic
incidents have been reported as well 1-7. our data fur-
ther  emphasize  the  clinical  significance  of  previously
demonstrated activation of the coagulation system dur-
ing excessive physical exercise [7-13, 15-19, 21-23, 32]. 
the  results  of  our  study  demonstrate  that  whole
blood coagulation is markedly altered during heavy en-
durance sports irrespective of the running fraction. In
contrast, elevated platelet aggregation is observed par-
ticularly during marathon and to a lesser extent also
during triathlon. We speculate that mechanical stress
during running may trigger platelet activation. thus,
the  higher  incidents  of  severe  thrombembolic  inci-
dents  in  otherwise  healthy  athletes  during  marathon
compared to triathlon or long distance cycling may be
explained by a marked activation of coagulation and
platelets at the same time. Influences like venous in-
sufficiency [33] may also contribute to a greater risk in
runners. 
Changes in hemostatic and fibrinolytic markers dur-
ing marathon running were discovered more than 30
years ago [12]. at that time the authors demonstrated
a significant shortening of partial thromboplastin time
while plasma fibrinogen levels and prothrombin times
were not altered. By finding shortened euglobulin lysis
times and increased levels of fibrin degradation prod-
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Fig. 2. Maximum clot firmness in fibrin polymer-
ization before and after competition as assessed by
rotational thrombelastometry (fIBtEM assay). Re-
sults significantly increased in all groups. * p<0.05.
Fig. 3. Results of platelet aggregation after stimulation by adenosine-di-phosphat (adP, left panel) and thrombin activating
peptide 6 (tRaP, right panel) as assessed by multiple platelet function analysis before and after competition. note, that signifi-
cant increases between pre and post competition (* p<0.05t) are found in marathon after adP and tRaP activation and in
triathlon after adP activation only, indicating that platelet activation during prolonged activity is dependent on its running 
fraction.
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coagulation and fibrinolysis are globally activated. In
addition, the concentration of prothrombin fragment
1+2 concentration as well as thrombin-antithrombin
complexes in plasma increased indicating activated co-
agulation. finally, the plasma concentrations of tissue
plasminogen activator antigen, plasminogen activator
inhibitor type 1 antigen, d-dimer and plasma fibrino-
gen  degradation  products  increased  in  parallel  con-
firming  activated  fibrinolysis  [15].  accordingly,  both
coagulation and fibrinolytic activation occurs during a
marathon run at the same time.
In contrast, a two hour treadmill exercise at an indi-
vidual anaerobic threshold of 90% [10] showed only a
small increase in thrombin generation markers, but a
distinct increase in fibrinolysis. While moderate exer-
cise led to an increase in plasmin formation only, very
heavy exercise also inducted thrombin and fibrin gen-
eration balanced by an increase in plasmin generation
[22].  similar  results  were  reported  for  two  hour
triathlon demonstrating a moderate activation of co-
agulation as indicated by  thrombin and fibrin forma-
tion accompanied by markedly increased plasmin for-
mation [34].  thus, during exercise free of heavy run-
ning periods activation of coagulation and fibrinolysis
does not occur in favour of increased fibrinolysis. 
the  effect  of  endurance  sports  on  platelets  and
their activation was assessed during marathon by Rock
[16] and dimitradou [9], during triathlon by Mockel
[14] and during a cycle ergometer test by li [35]. all
studies report on platelet activation during physical ac-
tivity, but a comparison of these sports using identical
methods had not been performed previously. While all
these studies were able to demonstrate platelet activa-
tion during heavy exercise they were not designed to
distinguish between various disciplines and did not re-
late these findings to variables of coagulation.
While most studies on coagulation changes during
physical  activity  assessed  more  or  less  isolated  vari-
ables describing coagulation by measuring single clot-
ting  factors  or  decomposition  products,  rotational
thrombelastometry analyzes both, clotting times and
the stability of the clot over the time. since rotational
thrombelastometry is performed in whole blood, its
results are affected by interaction of platelets, clotting
factors,  fibrin  polymerization  and  fibrinolysis,  giving
information about the end product of coagulation, the
clot itself, displaying overall coagulation activity. this
method was validated in a model of systemic activa-
tion of fibrinolysis and coagulation [20]. Whole blood
coagulation  in  marathon  runners  demonstrated  de-
creased  clotting  times  and  increased  clot  stability  in
runners after participating a downhill marathon [21].
our results are consistent with these alterations in co-
agulation after intrinsically activation. However, fibrin
polymerization was not tested and whole blood coagu-
lation in other endurance sports has not been analyzed
to date. the IntEM assay was chosen with regard to
the previously published study to confirm their find-
ings during a marathon and to compare these findings
to other endurance sports. the fIBtEM assay allows
excluding platelet function from the whole blood co-
agulation assay and displays fibrin polymerization only.
since fibrinogen is an acute phase protein and inflam-
mation during heavy exercise is a matter of discussion
we  decided  to  include  this  particular  test  into  our
study.  Platelet  function  itself  is  not  accurately  mir-
rored during RotEM analysis. accordingly, we evalu-
ated  platelet  function  by  multiple  platelet  function
analysis  (Multiplate,  dynabyte,  Munich,  germany).
for  reproduction  of  results  from  platelet  activation
during a marathon after adP activation which were
previously  described  [9,  16,  21,  35]  we  activated
platelets with adP. since tRaP-6 is recognized as an
even stronger platelet activator we also decided to in-
clude tRaP-6 activation.
Clotting times in rotational thrombelastometry mir-
ror activity of coagulation factors and were shortened
throughout the tested groups indicating an increase of
coagulation factor activity during heavy physical exer-
cise. In contrast, maximum clot firmness is mostly in-
fluenced  by  fibrin  polymerization  and  platelet  func-
tion. In a perioperative setting it is shown that elevated
results of maximum clot firmness in thrombelastome-
try strongly correlate with the incidence of postopera-
tive thromboembolic events and myocardial infarction
[36]. furthermore, increased platelet activation also el-
evates  the  thrombembolic  risk  [37,  38].  We  found
whole  blood  coagulation  parameters  increased  in  all
tested groups, while platelet aggregation was altered
during marathon and to a lesser extent during triathlon
but not during cycling, conclude that the running frac-
tion is responsible for platelet activation, while an acti-
vation of the plasmatic coagulation system is triggered
by physical activity itself. strenuous exercise activates
coagulation probably due to inflammatory effects as
shown  by  previously  published  studies  [21,  39].  We
found increasing leukocyte levels in all groups match-
ing these results. greater increases of leukocyte levels
in marathon and triathlon might indicate greater in-
flammatory effects of these endurance sports. More-
over, we speculate that comparable to effects of me-
chanical stress during prolonged running on red blood
cells  leading  to  hemolysis  [40-42],  direct  mechanical
stress  on  circulating  platelets  during  running  con-
tributes to the observed platelet activation. 
lIMItatIons
Participants  in  the  cycling  group  were  slightly  older
compared to the marathon and triathlon group. How-
ever, there are no indicators that coagulation and fibri-
nolysis may be different at baseline when comparing
subjects at age 41 and age 35. training status may flaw
baseline coagulation and fibrinolysis. However, this in-
fluence could be excluded since the duration of week-
ly training periods did not differ between the groups
studied. since we did not evaluate fibrinolysis further
studies may clarify whether the enhanced whole blood
coagulation  and  platelet  aggregation  during  ex  vivo
test may be balanced by increased fibrinolysis. 
the  use  of  antithrombotic  strategies  has  been
shown to be effective in other not desease related sit-
uations of prothrombotic stages like thrombembolic
events  during  air  travel  [43].  Whether  this  also  ac-
counts for marathon running can not be assessed by
our study and should be investigated in further stud-
ies.
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In  summary,  we  compared  whole  blood  coagulation
and  platelet  aggregation  during  different  forms  of
strenuous exercise. Irrespective of the type of exercise
(marathon, triathlon, long distance cycling) marked ac-
tivation of coagulation is observed. In contrast, only
during  marathon  and  to  a  lesser  extend  during  tri  -
athlon  a  significant  increase  in  platelet  aggregabilty
was found. We speculate that platelet activation is in-
duced by mechanical stress on thrombocytes and/or
inflammation.  finally,  our  data  may  explain  the  in-
creased  risk  for  thrombembolic  events  in  otherwise
healthy subjects particularly during marathon. 
the knowledge of running dependent platelet and
coagulation activation may trigger an even more care-
ful evaluation of athletes involved in marathon run-
ning. accordingly, future studies are necessary to de-
fine variables or tests that may identify athletes at risk
for thrombembolic events prior to competition.
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